NEW YORK, Oct. 2 – Cellomics of Pittsburgh said Tuesday it sold its ArrayScan High Content Screening system to Serono Pharmaceutical Research Institute, a subsidiary of Serono International of Switzerland.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.